Resource Logo
CDC HIV/AIDS/Viral Hepatitis/STD/TB Prevention News Update

UNITED STATES: U.S. Faces Drug Shortages in Treating Multidrug-Resistant TB


Chicago Tribune (01.17.13)

More than 80 percent of US health departments that treat multidrug-resistant tuberculosis (MDR TB) have difficulty obtaining treatment drugs. Based on the results of the National Tuberculosis Controllers Association’s 2010 survey, the difficulty is blamed on shortages, shipping delays, and a complicated new drug acquisition process. Of the 33 health departments that responded to the survey, 26 had patients with MDR TB in the five years the survey covered and 21 of them had difficulty finding the second-line drugs needed. More than half of the 26 health departments that treated a drug-resistant strain of TB (81 percent) complained of difficulty finding drugs for the disease, and more than half said problems finding the proper drugs for MDR TB delayed patient treatment. According to CDC statistics, the United States reported 10,258 TB cases in 2011,and 529 deaths from TB in 2009. CDC noted that because only 54 percent of 61 health jurisdictions approached responded to the survey, the results might not accurately represent the national drug shortage problem.


Copyright © 2013 -CDC Prevention News Update, Publisher. All rights reserved to Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles.

Information in this article was accurate in January 22, 2013. The state of the art may have changed since the publication date. This material is designed to support, not replace, the relationship that exists between you and your doctor. Always discuss treatment options with a doctor who specializes in treating HIV.